← Back to Search

Skin Biopsies for Genitourinary Neoplasms

N/A
Waitlist Available
Led By Sumanta K Pal
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial looks at whether the bacteria on the skin is different in patients with a rash caused by immunotherapy treatment.

Eligible Conditions
  • Genitourinary Neoplasms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Association between skin microbial diversity and immune checkpoint inhibitor (ICI)-induced dermatitis
Other outcome measures
Abundances of certain skin bacteria in lesion
Skin microbial diversity
Specific skin bacteria
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Skin BiopsiesExperimental Treatment1 Intervention
Patients undergo punch biopsies of inflamed and non-inflamed skin and a blood sample collection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection(Punch Biopsy)
2021
N/A
~10

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,151 Total Patients Enrolled
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,458 Total Patients Enrolled
Sumanta K PalPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
351 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this testing protocol currently recruiting participants?

"According to the clinicaltrials.gov site, this particular medical trial is not currently admitting participants as it was last updated in November of 2022; however, there are more than two hundred other trials that are actively recruiting patients at present time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis
2021. "Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04812197.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top